Fluticasone Air

Pulmonology

Fluticasone Air

Registration certificate:

INN:

Fluticasone

Release form:

Metered Dose Inhaler (MDI)

Therapeutic Area:

Pulmonology

Pharmacotherapeutic Group:

Glucocorticosteroid for local use

Conditions for dispensing:

On prescription

Packaging:

Indications:

Basic anti-inflammatory therapy for bronchial asthma in adults and children aged 1 year and older (including patients with severe disease dependent on systemic corticosteroids)
Treatment of chronic obstructive pulmonary disease (COPD) in adults as an adjunct to long-acting bronchodilator therapy

Fluticasone Air is not in the Essential Medicines List.